Answers are grounded in this paper and cite their sources.
Because 1% to 9% of people without symptoms have elevated liver enzymes, extensive evaluation of all abnormal test results would expose many patients to undue risks and expenses. On the other hand, failure to evaluate minor liver enzyme elevations could mean missing the early diagnosis of potentially treatable disorders. This review discusses likely causes of elevated aminotransferase, alkaline phosphatase, and gamma-glutamyl transferase levels and provides algorithms for evaluating high liver enzyme values in apparently healthy patients in the primary care setting.
No takes yet. Share an insight, caveat, or question.
Aragon et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: